Phase 1 Recurrent Non-small Cell Lung Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Non-small Cell Lung CancerStage IV Non-Small Cell Lung CancerRecurrent Non-small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute20 enrolled1 locationNCT05681780

Recruiting

Phase 1

A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer

Shanghai Jiao Tong University School of Medicine500 enrolled3 locationsNCT02889666